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creativecommons.org/licenses/by-nc-nd/3.0/Schizophrenia is a common and complex psychiatric disease
with a high estimated heritability of approximately 80%
(Sullivan, Kendler, & Neale, 2003), and hundreds of common
single-nucleotide polymorphisms (SNPs) are weakly impli-
cated in the pathogenesis of schizophrenia (Purcell et al.,Center for Children's Men
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).2009). Gray matter volume (GM) in brain also has an esti-
mated heritability of approximately 60e90% in healthy sub-
jects (Thompson et al., 2001) and reduced GM volumes in
patients with schizophrenia have been frequently reported
(Chan, Di, McAlonan, & Gong, 2011). A single polygenictal Development, United Graduate School of Child Development,
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c o r t e x 5 8 ( 2 0 1 4 ) 2 3e2 624schizophrenia score (PSS), whichwas calculated by combining
the additive effects of thousands of common independent
SNPs weakly associated with schizophrenia explained
approximately 3% of the variance in liability for schizophrenia
in independent subjects (Purcell et al., 2009). A recent study
found that PSS predicts the total brain (TB) and white matter
volumes (WM) but not the GM, explaining approximately 5% of
the variance in the TB and WM (Terwisscha van Scheltinga
et al., 2013). However, it remains unclear whether PSS af-
fects variation in specific GM. Therefore, we investigated the
effect of PSS on GM, using (i) voxel-based morphometry (VBM)
and (ii) VBM-based region of interest (ROI) methods.
For PSS, the odds ratios for genome-wide SNP data were
calculated in a discovery Japanese genome-wide association
study (JPN_GWAS) sample including 560 patients with
schizophrenia and 548 healthy subjects (Ikeda et al., 2011). On
the basis of the genomic-control adjusted p-values in an
allele-wise association analysis from the discovery sample,
nominally associated alleles at the following liberal signifi-
cance threshold (PT) were selected: PT  .1, PT  .2, PT  .3,
PT .4, and PT .5. Of 67,315 independent SNPs remained after
pruning, the numbers of SNPs at each PT are as follows; PT  .1
(n ¼ 7,332), PT  .2 (n ¼ 14,294), PT  .3 (n ¼ 21,205), PT  .4
(n ¼ 27,921), and PT  .5 (n ¼ 34,523). These data were used to
calculate individual PSSs in our target sample of 160 patients
with schizophrenia and 378 healthy subjects. The structural
images in the target sample were acquired using a 1.5T GE
Magnetic Resonance Imaging (MRI) scanner, and the MRI im-
ages were processed using the VBM8 toolbox in StatisticalFig. 1 e Impacts of polygenic scores on gray matter volume in pa
threshold (PT ≤ .1, PT ≤ .2, PT ≤ .3, PT ≤ .4, and PT ≤ .5) on the gray
by the colored bars. The most significant region of PSS associa
coordinates of peak voxel: ¡50, ¡3, ¡9). The anatomical localiz
(middle line) sections of a normal MRI spatially normalized to t
represent the z and y coordinates in Talairach space. The surfac
with PSS is shown. L, left; R, right; A, anterior; P, posterior.Parametric Mapping 8 (SPM8). Detailed information regarding
the subjects and methods is provided in the Supplementary
Materials and Methods and Table S1. Written informed con-
sent was obtained from all subjects after the procedures had
been fully explained. This study was performed in accordance
with the World Medical Association's Declaration of Helsinki
and was approved by the Research Ethical Committee of
Osaka University.
First, to identify brain regions related to PSS based on each
threshold, we conducted a whole-brain search in patients
with schizophrenia and healthy subjects using a multiple
regression model in SPM8. Age, gender and diagnosis were
included as covariates. As we found a marginal interaction
between diagnosis and PSS on the left superior temporal gyrus
(STG), an area of the brain reported to have reduced GM in
high-risk individuals and first-episode and chronic schizo-
phrenia patients (Chan et al., 2011) (a maximum of T ¼ 4.44
and PFWE¼ .075 at PT .5) (Fig. S1), we next performed separate
whole-brain searches to examine the effects of PSS in patients
with schizophrenia and healthy subjects. In the patients, PSS
was significantly negatively correlated with the local GM in
the left STG at the different PT-values at the whole-brain
corrected level (PFWE < .05, a maximum of T ¼ 5.04 and
PFWE¼ .012 at PT .3) (Fig. 1). Higher PSSswere associatedwith
smaller left STG volumes. The STG was the only region
showing the association. Such effects were similarly found at
the PT .2 (T¼ 4.75, PFWE¼ .037) to PT .5 (T¼ 4.73, PFWE¼ .040)
threshold levels, indicating that many more SNPs based on
threshold levels more lenient than PT  .2 are predictive oftients with schizophrenia. The effects of PSS based on each
matter volume are shown according to the t values showed
tion was in the left superior temporal gyrus (Talairach
ations are displayed on the axial (upper line) and coronal
he Montreal Neurological Institute template. Z and y
e-rendered view (lower line) of the brain region correlating
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missing SNPs, PANSS scores, duration of illness, or antipsy-
chotic dosage as covariates in the VBM analysis, the effects of
PSS on the region remained significant (PFWE< .05). In contrast,
there was no effect of the score on the GM in healthy subjects
(PFWE > .05).
The STG is involved in auditory processing, the perception
of emotions in facial stimuli, and social cognition (Bigler et al.,
2007; Radua et al., 2010). To confirm whether the effect at
voxel level on the initial VBM analyses is accepted in the larger
structural and functional region, we secondly investigated the
effects of PSS on calculated total left STG volumes in patients
with schizophrenia and healthy subjects using a multiple
linear regressionmodel, with the number of nonmissing SNPs
as a covariate using PASW18.0 software. Consistent with the
VBM results and expected from them, the ROI analysis
revealed that the PSS were significantly negatively correlated
with the total left STG volume at all different PT-values (a
maximum R2 ¼ .032, p ¼ .0090, at PT  .2) in the patients
(Fig. S2), whereas therewas no effect of the score on the region
in the controls (p > .13). The PSS explained approximately 3.2%
of the variance in the total left STG in the patients with
schizophrenia, and the effects of PSS on the region reached a
peak at PT  .3 in the VBM and PT  .2 in the ROI analyses. To
examine whether there is a strong association of SNPs with
the total left STG, we subsequently conducted a GWAS of the
region in the same target samples of patients with schizo-
phrenia. We did not observe any association at a widely used
benchmark for genome-wide significance (p > 5.0  108, Figs.
S3eS4 and Table S2).
Although Ikeda et al. (2011) reported that there was a sig-
nificant correlation of the PSSs between the Japanese and UK
samples, there are likely many unique risk variants included
in the PSS derived in the Japanese dataset. As the genes
comprising the PSS in this study are not identical to those in
the MRI study of Terwisscha van Scheltinga et al. (2013), we
additionally attempted to replicate the association between
PSS and TB and WM (Fig. S5). The PSS were marginally nega-
tively correlated with the TB at the PT  .5 (R2 ¼ .0035, p ¼ .049)
and GM at different PT-values (amaximum R
2¼ .0073, p¼ .015,
at PT .5), whereas there was no effect of the score on theWM
(p > .05). The reason why we failed to replicate the associa-
tions may be caused by false-negative results due to a small
number of discovery samples and/or difference of ethnicities
between present and previous studies. We used liberal
thresholds (PT ¼ .1 to .5) to obtain PSS according to prior
studies (Ikeda et al., 2011; Purcell et al., 2009). However, it was
more liberal compared to previous study of Terwisscha van
Scheltinga et al. (2013) (PT ¼ .002 to .4). The thresholds we
usedwere so liberal as to likely include a large number of false
positives.
Substantially larger controls participated in this study.
However, there was a lack of the association in the group. As
demographic variables in our samples did not match between
healthy subjects and patients with schizophrenia, we
matched controls to patients for age and sex and additionally
performed the VBM analysis, by removing healthy subjects
from the total samples. However, the lack of association in the
control group did not change. We considered two reasons for
the lack of association; 1) The PSS may be related to a geneticarchitecture of patients with schizophrenia but not controls
because the PSS were scores derived from risk of schizo-
phrenia. 2) The association that we detected in patients may
result from a false-positive finding due to small samples.
Our findings suggest that a set of SNPs weakly associated
with schizophrenia may have an accumulative effect on the
brain structure of patients, but not controls. However, our
findings should be carefully interpreted because there has not
been enough evidence for the heritability of brain structures
in unaffected siblings (Birnbaum & Weinberger, 2013). It is
interesting to note that the STG is the only brain region
showing significant association with the PSS in our schizo-
phrenia dataset, even though structural imaging studies of
patients with schizophrenia have identified other brain re-
gions that show volume differences between patients and
controls, and that no associations were found in normal
subjects, a considerably larger sample. This selective associ-
ation with the STG and only in the patients was not expected
and must be viewed as preliminary pending further
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